Mary Ziping Luo is a distinguished professional in the pharmaceutical industry, currently serving as the Chief Operating Officer, Chief Scientist, and Chairman at Amphastar Pharmaceuticals Inc. With a robust background in chemical engineering, Luo has been instrumental in steering the company towards significant growth and innovation. She holds a Ph.D. in Chemical Engineering from the University of California, Los Angeles (UCLA), which has equipped her with the technical expertise necessary to lead Amphastar's scientific endeavors. At Amphastar Pharmaceuticals, Mary Ziping Luo's multifaceted role encompasses overseeing the company's operational strategies, leading scientific research and development, and guiding the overall direction as Chairman. Her leadership has been pivotal in expanding the company's product portfolio, which includes complex generic and biosimilar drugs. Under her guidance, Amphastar has successfully navigated the competitive landscape of the pharmaceutical industry, achieving notable milestones such as the approval and commercialization of several critical medications. Luo's strategic vision and commitment to excellence have solidified Amphastar's position as a leader in the development of high-quality, affordable pharmaceuticals. Mary Ziping Luo's achievements extend beyond her corporate responsibilities. She is recognized for her contributions to the field of chemical engineering and pharmaceuticals, often speaking at industry conferences and contributing to academic journals. Her dedication to advancing healthcare solutions and her leadership in fostering a culture of innovation at Amphastar Pharmaceuticals have earned her respect and admiration within the industry. As Amphastar continues to grow, Luo's influence remains central to the company's mission of improving patient outcomes through cutting-edge pharmaceutical solutions.